BRIEF-EMA adopts positive opinion on expanded approval of Gilead's HIV drug, Truvada

* European CHMP adopts positive opinion on Gilead's type II variation application for Truvada for reducing the risk of sexually acquired HIV.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.